J. Arrizabalaga

发表

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients.

M. Goenaga, E. Bereciartúa, J. Iribarren, 2018 .

Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.

D. Podzamczer, M. Plana, A. Cruceta, 2010, AIDS research and human retroviruses.

Prevalence of HLA-B*5701 in HIV-Infected Patients in Spain (Results of the EPI Study)

D. Podzamczer, R. Dal-Ré, J. L. Castañer, 2009, HIV clinical trials.

Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed.

D. Otaegui, I. Vergara, J. Arrizabalaga, 2020, F1000Research.

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

F. Díez-Fuertes, J. Alcamí, M. Pérez-Olmeda, 2022, eClinicalMedicine.

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitors.

J. Gatell, J. Mallolas, C. Tortajada, 1997, AIDS.

Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases.

C. Quereda, J. Peña, J. L. Villanueva, 2003, Chest.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy

C. Tural, R. Schuurman, J. Casado, 1999 .

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.

C. Tural, R. Schuurman, J. Casado, 1999, AIDS.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

AIDS-associated cryptosporidiosis with antral narrowing. A new case.

A. Castiella, J. Iribarren, J. Arrizabalaga, 1997, Journal of clinical gastroenterology.

Brucellosis in patients infected with the human immunodeficiency virus

D. Podzamczer, J. Miro, A. Rivero, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

J. Romeu, Felipe García, A. Cruceta, 2000, AIDS.

Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine.

F. Pulido, P. Domingo, A. Ocampo, 2013, The Journal of antimicrobial chemotherapy.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

D. Podzamczer, B. Clotet, J. Romeu, 1999, AIDS.

CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.

J. Iribarren, J. Arrizabalaga, P. Echaniz, 1993, Cellular immunology.

Prevention of opportunistic infections in HIV-infected adolescent and adult patients . Guidelines from GESIDA / National AIDS Plan , 2008

D. Podzamczer, Miguel, Moreno, 2009 .

Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis.

D. Podzamczer, M. Lejeune, Felipe García, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients

D. Podzamczer, A. Cruceta, J. Miro, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Molecular evidence of homosexual transmission of HIV type 2 in Spain.

B. Rodés, V. Soriano, G. Cilla, 2001, AIDS research and human retroviruses.

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

R. Paredes, L. Ruiz, J. Romeu, 1999, Antiviral therapy.

Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

J. Mallolas, E. Ribera, M. Márquez, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed

Eva Méndez, D. Otaegui, I. Vergara, 2020, F1000Research.

Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy.

A. Castiella, J. Arenas, J. Iribarren, 1997, The American journal of medicine.

[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].

B. Clotet, J. Miro, J. Gatell, 2004, Enfermedades infecciosas y microbiologia clinica.

Pseudomonas Aeruginosa Cholangitis in a HIV Patient

A. Castiella, J. Iribarren, J. Arrizabalaga, 1998, American Journal of Gastroenterology.

[Resistance to protease inhibitors].

B. Clotet, J. Martinez-Picado, J. Arrizabalaga, 2001, Enfermedades infecciosas y microbiologia clinica.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].

J. Miro, A. Antela, P. Viciana, 2000, Enfermedades infecciosas y microbiologia clinica.

[Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy].

J. Iribarren, J. Arrizabalaga, F. Rodríguez, 2001, Enfermedades infecciosas y microbiologia clinica.

[Cytomegalovirus infection in AIDS].

J. Iribarren, J. Arrizabalaga, F. Rodríguez-Arrondo, 1994, Enfermedades infecciosas y microbiologia clinica.

[Invasive aspergillosis in patients infected by the human immunodeficiency virus].

J. Iribarren, J. Arrizabalaga, F. Rodríguez-Arrondo, 1991, Enfermedades infecciosas y microbiologia clinica.

Candidal meningitis in HIV-infected patients: treatment with fluconazole.

M. Goenaga, J. Iribarren, J. Arrizabalaga, 1998, Scandinavian journal of infectious diseases.

[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].

J. Miro, J. Gatell, E. Martinez, 2002, Enfermedades infecciosas y microbiologia clinica.

Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study).

D. Podzamczer, R. Dal-Ré, J. L. Castañer, 2009, HIV clinical trials.

cholangitis in a HIV patient

A. Castiella, J. Iribarren, J. Arrizabalaga, 1998 .

[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].

B. Clotet, J. Miro, J. Gatell, 2004 .

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

B. Clotet, J. Romeu, A. Cruceta, 2000, Journal of acquired immune deficiency syndromes.

A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients.

M. Goenaga, J. Iribarren, M. Montejo, 2017, Medicina clinica.

Possibility of heterosexual transmission of hepatitis C virus

G. Cilla, E. Pérez-Trallero, M. Iturriza, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

R. López-Vélez, J. Mallolas, E. Ribera, 2004, Enfermedades infecciosas y microbiologia clinica.

Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

E. Ribera, M. Márquez, P. Domingo, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.